Risk-based approach to rescue regions of low coverage in targeted NGS sequencing

High-throughput clinical genetic testing assays based on next generation sequencing often rely on Sanger sequencing to “rescue” or “backfill” regions with low coverage in order to detect variants with high sensitivity. This can lead to a longer turn-around time, higher cost, and excessive workload burden on the laboratory performing the testing. In response to these challenges, a data-driven computational approach was developed to reduce the total false negative call risk in a sample by designating a subset of high-risk gene segments for rescue testing, instead of performing rescue testing for all the low-coverage segments in a patient sample. This approach maintains the high sensitivity required for clinical testing while significantly reducing the number of targeted Sanger tests needed.

Authors

Institutions

Publication Details

Journal
Scientific Reports
Published
2026-07-22
DOI
https://doi.org/10.1038/s41598-026-63567-z
Primary Topic
Genomics and Rare Diseases
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Risk-based approach to rescue regions of low coverage in targeted NGS sequencing

Eldar Giladi, Binbin Huang, Qiandong Zeng, Angela Kenyon et al.
Scientific Reports
Genomics and Rare Diseases
article

Risk-based approach to rescue regions of low coverage in targeted NGS sequencing

Eldar Giladi, Binbin Huang, Qiandong Zeng, Angela Kenyon, Stanley Letovsky
article en

Abstract

High-throughput clinical genetic testing assays based on next generation sequencing often rely on Sanger sequencing to “rescue” or “backfill” regions with low coverage in order to detect variants with high sensitivity. This can lead to a longer turn-around time, higher cost, and excessive workload burden on the laboratory performing the testing. In response to these challenges, a data-driven computational approach was developed to reduce the total false negative call risk in a sample by designating a subset of high-risk gene segments for rescue testing, instead of performing rescue testing for all the low-coverage segments in a patient sample. This approach maintains the high sensitivity required for clinical testing while significantly reducing the number of targeted Sanger tests needed.

Scientific Reports
LabCorp (United States) (US)
Openalex Percentile: Top 8%
Genomics and Rare Diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.